Cargando…

The real-life heart failure patient: importance of guideline-directed medical therapy

Detalles Bibliográficos
Autores principales:	van Hout, G. P. J., van der Meer, M. G.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Bohn Stafleu van Loghum 2021
Materias:	Commentary
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8271073/ https://www.ncbi.nlm.nih.gov/pubmed/34138440 http://dx.doi.org/10.1007/s12471-021-01596-1

Ejemplares similares

Haemodynamic monitoring as an opportunity for tailoring diuretics and guideline‐directed medical therapy in heart failure
por: Malgie, Jishnu, et al.
Publicado: (2023)

Mortality and guideline‐directed medical therapy in real‐world heart failure patients with reduced ejection fraction
por: McCullough, Peter A., et al.
Publicado: (2021)

Right ventricular dysfunction in patients with new‐onset heart failure: longitudinal follow‐up during guideline‐directed medical therapy
por: Ansari Ramandi, Mohammad Mostafa, et al.
Publicado: (2022)

The role of discharge checklist in guideline-directed medical therapy for heart failure patients
por: Rismiati, Helsi, et al.
Publicado: (2023)

Novel Strategies to Improve Prescription of Guideline-Directed Medical Therapy in Heart Failure
por: Brooksbank, Jeremy A., et al.
Publicado: (2023)

Advanced heart failure: guideline‐directed medical therapy, diuretics, inotropes, and palliative care
por: Tomasoni, Daniela, et al.
Publicado: (2022)

Phenotypic patient profiling for improved implementation of guideline-directed medical therapy: An exploratory analysis in a large real-world chronic heart failure cohort
por: Radhoe, Sumant P., et al.
Publicado: (2023)

Multimorbidity, guideline‐directed medical therapies, and associated outcomes among hospitalized heart failure patients
por: Takeuchi, Shinsuke, et al.
Publicado: (2022)

Guideline-directed medical therapy is similarly effective in heart failure with mildly reduced ejection fraction
por: Straw, Sam, et al.
Publicado: (2022)

Frailty interferes with the guideline‐directed medical therapy in heart failure patients with reduced ejection fraction
por: Hamada, Tomoyuki, et al.
Publicado: (2022)

A scoring evaluation for the practical introduction of guideline‐directed medical therapy in heart failure patients
por: Matsukawa, Ryuichi, et al.
Publicado: (2023)

Emerging concepts in heart failure management and treatment: focus on current guideline-directed medical therapy for heart failure with reduced ejection fraction
por: Ospina González, Oscar Eduardo, et al.
Publicado: (2023)

Guideline-directed therapy at discharge in patients with heart failure and atrial fibrillation
por: Ahn, Min-Soo, et al.
Publicado: (2020)

The Important Difference Between Psychologists’ Labs and Real Life: Evaluating the Validity of Models of Wisdom
por: Glück, Judith
Publicado: (2020)

IMPACT OF REMOTE TITRATION COMBINED WITH TELEMONITORING ON THE OPTIMIZATION OF GUIDELINE DIRECTED MEDICAL THERAPY FOR PATIENTS WITH HEART FAILURE
por: Artanian, V., et al.
Publicado: (2020)

Evaluation of the prescribing practice of guideline-directed medical therapy among ambulatory chronic heart failure patients
por: Parajuli, Daya Ram, et al.
Publicado: (2021)

Impact of Pharmacist-Led Heart Failure Clinic on Optimization of Guideline-Directed Medical Therapy (PHARM-HF)
por: Patil, Tanvi, et al.
Publicado: (2022)

Impact of Digoxin Use on Guideline-Directed Medical Therapy in Patients With Heart Failure With Reduced Ejection Fraction
por: Jabri, Ahmad, et al.
Publicado: (2022)

In-hospital Initiation and Up-titration of Guideline-directed Medical Therapies for Heart Failure with Reduced Ejection Fraction
por: Cox, Zachary L, et al.
Publicado: (2022)

Perspectives on the Evolution of Stem Cell Therapy for Heart Failure
por: Tompkins, Bryon, et al.
Publicado: (2015)

Successful glucose lowering therapy triumphs in heart failure
por: Rossing, Peter
Publicado: (2021)

Real-world management of heart failure in the Netherlands: Improving quality of care by simple measures
por: Koudstaal, S., et al.
Publicado: (2018)

A machine learning evaluation of patient characteristics associated with prescribing of guideline-directed medical therapy for heart failure
por: Kim, Rachel, et al.
Publicado: (2023)

Real‐World Analysis of Guideline‐Based Therapy After Hospitalization for Heart Failure
por: Wirtz, Heidi S., et al.
Publicado: (2020)

Clinical importance of urinary sodium excretion in acute heart failure
por: Damman, Kevin, et al.
Publicado: (2020)

Congenital toxoplasmosis: the importance of implementing clinical practice guidelines
por: Amendoeira, Maria Regina Reis, et al.
Publicado: (2021)

Differences in guideline-recommended heart failure medication between Dutch heart failure clinics: an analysis of the CHECK-HF registry
por: Linssen, G. C. M., et al.
Publicado: (2020)

Evaluation of a guideline directed medical therapy titration program in patients with heart failure with reduced ejection fraction
por: Balakumaran, Kathir, et al.
Publicado: (2018)

Guideline-directed medical therapy in elderly patients with heart failure with reduced ejection fraction: a cohort study
por: Seo, Won-Woo, et al.
Publicado: (2020)

Association between Education Attainment and Guideline-Directed Medication Therapy in Patients with Heart Failure and Reduced Ejection Fraction
por: Long, Juan, et al.
Publicado: (2022)

CardioMEMS: the next revolution in heart failure management?
por: Handoko, M. L., et al.
Publicado: (2019)

Guideline-directed medical therapy in heart failure patients: impact of focused care provided by a heart failure clinic in comparison to general cardiology out-patient department
por: Joseph, Jeeva, et al.
Publicado: (2020)

Referral of patients with chronic kidney disease: inconsistencies between guidelines and real-life practice, more questions than answers
por: Torreggiani, Massimo
Publicado: (2022)

Efficacy of guideline‐directed medical treatment in heart failure with mildly reduced ejection fraction
por: Zhang, Xinxin, et al.
Publicado: (2022)

Optimization of guideline-directed medical treatment for heart failure patients with reduced ejection fraction
por: Bak, Minjung, et al.
Publicado: (2023)

Adherence to guideline-directed medical and device Therapy in outpAtients with heart failure with reduced ejection fraction: The ATA study
por: Kocabaş, Umut, et al.
Publicado: (2020)

TELE-PHARMACY CARE OF GUIDELINE-DIRECTED MEDICAL THERAPY IN HEART FAILURE PATIENTS IS FEASIBLE DURING THE COVID-19 PANDEMIC
por: Randhawa, Varinder, et al.
Publicado: (2021)

Use of Guideline-Directed Medical Therapy in Patients Aged 80 Years or Older With Heart Failure With Reduced Ejection Fraction
por: Barry, Arden R., et al.
Publicado: (2023)

Clinical application of sodium-glucose cotransporter 2 inhibitor into a real-world setting of heart failure care
por: Tanaka, Atsushi, et al.
Publicado: (2020)

Prognostic Effect of Guideline-Directed Therapy Is More Noticeable Early in the Course of Heart Failure
por: Ahn, Min-Soo, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_kjpa6m69ihffgugdkoqqrveh7j